Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10196393 JAK inhibitors containing a 4-membered heterocyclic amide

Patent 10196393 was granted and assigned to Theravance on February, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Paul R. Fatheree0

Cameron Smith0

Gary E. L. Brandt0

Lori Jean Van Orden0

Steven D. E. Sullivan0

Date of Patent

February 5, 2019

0

Patent Application Number

159154180

Date Filed

March 8, 2018

0

Patent Citations Received

US Patent 12122773 Crystalline hydrate of a JAK inhibitor compound

0

US Patent 11254669 Fused imidazo-piperidine JAK inhibitors

US Patent 11634419 Dimethyl amino azetidine amides as JAK inhibitors

0

US Patent 11667637 Fused imidazo-piperidine JAK inhibitors

0

US Patent 11702415 Crystalline hydrate of a JAK inhibitor compound

0

US Patent 11713315 5 to 7 membered heterocyclic amides as JAK inhibitors

0

US Patent 11299492 JAK kinase inhibitor compounds for treatment of respiratory disease

US Patent 11786517 Methods of treatment using a JAK inhibitor compound

...

Patent Primary Examiner

Joseph R Kosack

0

Patent abstract

The invention provides compounds of formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10196393 JAK inhibitors containing a 4-membered heterocyclic amide

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool